Skip to product information
1 of 1

Elabscience

SKU:PKSH031825

Recombinant Human tPA/PLAT Protein (aa 37-310, Fc Tag)

Recombinant Human tPA/PLAT Protein (aa 37-310, Fc Tag)

Regular price $612.00 USD
Regular price Sale price $612.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human TPA/PLAT Protein (AA 37-310, FC TAG), a cutting-edge product designed to revolutionize the field of biotechnology. This meticulously engineered protein, derived from human tissue plasminogen activator (TPA) and plasminogen activator inhibitor-1 (PLAT), showcases an impressive amino acid sequence spanning from 37 to 310, further enhanced by the fusion of a Fc tag.

Crafted with utmost precision, this recombinant protein exhibits exceptional purity and stability, ensuring optimal performance in a myriad of applications. Its strategic amino acid composition enables it to effectively interact with target molecules, facilitating the desired biological processes with unparalleled efficiency.

The inclusion of the Fc tag in this innovative formulation not only enhances the protein's solubility but also facilitates its purification, simplifying downstream applications. This fusion protein's unique attributes make it an invaluable tool for researchers and scientists alike, enabling them to delve deeper into the intricacies of various biological pathways.

The Recombinant Human TPA/PLAT Protein (AA 37-310, FC TAG) holds immense potential in a wide range of scientific endeavors, including but not limited to drug discovery, protein-protein interaction studies, and therapeutic development. Its versatility and reliability make it an indispensable asset in the pursuit of groundbreaking advancements in the field of biotechnology.

With its unrivaled quality and unwavering performance, this recombinant protein stands as a testament to our commitment to excellence. Embrace the future of biotechnology with the Recombinant Human TPA/PLAT Protein (AA 37-310, FC TAG) and unlock a world of possibilities in your research endeavors.
View full details